TO THE EDITOR:
In their recent article on the cost-effectiveness of dabigatran versus warfarin, Freeman and colleagues (1) did not account for some of the highest costs associated with warfarin administration. Each time that prothrombin time is measured, the logistics involved cost money. Patients must travel to the laboratory to have blood drawn, or family members must take them. If patients are homebound, the cost of visiting nurses is high.
The authors also did not account for the costs of prothrombin time measurement for physicians, patients, and caregivers. For example, when one of my patients undergoes measurement of prothrombin time, ...
Reference
- 1.
Freeman JV ,Zhu RP ,Owens DK ,Garber AM ,Hutton DW ,Go AS ,et al . Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011;154:1-11. [PMID:21041570 ] LinkGoogle Scholar
Author, Article and Disclosure Information
From Margolis Rheumatology Associates–University of Pittsburgh Medical Center, Pittsburgh, PA 15215.
Disclosures: None disclosed.

Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.